Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

返回 Agenda

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

Regulatory Affairs: Part 7: Mock FDA Meeting

Regulatory Affairs: The IND, NDA, and Post-Marketing

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Elliott Berger, PhD, MS

获得信息并保持参与